Skip to main content

Amicus Therapeutics, Inc.

FOLDDelisted Apr 27, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001178879

Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Amicus Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Amicus Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Amicus Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Whitman Burke WDirector0Apr 27, 20261
McGlynn Margaret GDirector0Apr 27, 20261
Wheeler Craig ADirector0Apr 27, 20261
Sblendorio GlennDirector0Apr 27, 20261
Raab MichaelDirector0Apr 27, 20261
Campbell Bradley LPresident and CEO0Apr 27, 20267
Harford Simon N.R.Chief Financial Officer0Apr 27, 20262
Castelli JeffChief Development Officer0Apr 27, 20263
Bleil Lynn DorseyDirector0Apr 27, 20261
Rosenberg EllenChief Legal Officer0IndirectApr 27, 20263
Roberts EiryDirector0Apr 27, 20261
Prout SamanthaChief Accounting Officer0Apr 27, 20263
Clark David MichaelChief People Officer0Apr 27, 20266
Kelly Michael AaronDirector0Apr 27, 20261
Crowley John FExecutive Chairman927,013Mar 15, 20240
Quimi DaphneChief Financial Officer398,532Jan 19, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 4, 2023 (view filing)Oct 22 daysCrowley John FExecutive ChairmanSSale−6.04K$11.25−$68.0K−0.7%908.0K after2 lots10b5-1
Oct 4, 2023 (view filing)Oct 22 daysCampbell Bradley LPresident & CEOSSale−11.7K$11.24−$131.5K−1.5%792.2K after2 lots10b5-1
Sep 18, 2023 (view filing)Sep 153 daysCrowley John FExecutive ChairmanSSale−6.04K$13.06−$78.9K−0.7%914.0K after10b5-1
Sep 6, 2023 (view filing)Sep 15 daysCrowley John FExecutive ChairmanSSale−6.04K$12.98−$78.5K−0.7%920.1K after10b5-1
Sep 6, 2023 (view filing)Sep 15 daysCampbell Bradley LPresident & CEOSSale−18.1K$12.97−$234.7K−2.2%792.2K after10b5-1
Aug 16, 2023 (view filing)Aug 151 dayCrowley John FExecutive ChairmanSSale−6.04K$13.03−$78.8K−0.6%926.1K after10b5-1
Aug 11, 2023 (view filing)Aug 92 daysProut SamanthaChief Accounting OfficerSSale−36.9K$14.01−$517.1K−21.2%137.0K after10b5-1
Aug 3, 2023 (view filing)Aug 12 daysCrowley John FExecutive ChairmanSSale−6.04K$13.35−$80.7K−0.6%932.1K after10b5-1
Aug 3, 2023 (view filing)Aug 12 daysCampbell Bradley LPresident & CEOSSale−20.0K$13.39−$267.8K−2.4%798.6K after10b5-1
Jul 19, 2023 (view filing)Jul 172 daysCrowley John FExecutive ChairmanSSale−6.04K$13.45−$81.3K−0.6%938.2K after10b5-1
Jul 14, 2023 (view filing)Jul 12-132 daysCampbell Bradley LPresident & CEOSSale−8.30K$12.51−$103.8K−1.0%806.9K after2 lots10b5-1
Jul 6, 2023 (view filing)Jul 33 daysCrowley John FExecutive ChairmanSSale−6.04K$12.31−$74.4K−0.6%944.2K after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysCampbell Bradley LPresident & CEOSSale−11.7K$12.31−$144.0K−1.4%815.2K after10b5-1
Jun 20, 2023 (view filing)Jun 155 daysCrowley John FExecutive ChairmanSSale−6.04K$13.04−$78.8K−0.6%950.3K after10b5-1
Jun 8, 2023 (view filing)Jun 62 daysCampbell Bradley LPresident & CEOSSale−8.30K$12.50−$103.8K−1.0%815.2K after10b5-1
Jun 5, 2023 (view filing)Jun 14 daysCrowley John FExecutive ChairmanSSale−6.04K$11.36−$68.7K−0.6%956.3K after10b5-1
Jun 5, 2023 (view filing)Jun 14 daysCampbell Bradley LPresident & CEOSSale−11.7K$11.36−$132.9K−1.4%823.5K after10b5-1
May 17, 2023 (view filing)May 152 daysCrowley John FExecutive ChairmanSSale−6.04K$11.18−$67.6K−0.6%962.4K after10b5-1
May 3, 2023 (view filing)May 12 daysCrowley John FExecutive ChairmanSSale−6.04K$11.80−$71.3K−0.6%968.4K after10b5-1
May 3, 2023 (view filing)May 12 daysCampbell Bradley LPresident & CEOSSale−11.7K$11.80−$138.1K−1.4%823.5K after10b5-1
Apr 19, 2023 (view filing)Apr 172 daysCrowley John FExecutive ChairmanSSale−6.04K$11.66−$70.5K−0.6%974.4K after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysCrowley John FExecutive ChairmanSSale−6.04K$11.22−$67.8K−0.6%980.5K after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysCampbell Bradley LPresident & CEOSSale−11.7K$11.21−$131.2K−1.4%823.5K after10b5-1
Mar 21, 2023 (view filing)Mar 174 daysRaab MichaelDirectorSSale−4.41K$11.33−$49.9K−6.8%60.0K after
Mar 17, 2023 (view filing)Mar 152 daysCrowley John FExecutive ChairmanSSale−6.04K$11.34−$68.5K−0.6%986.5K after
Mar 3, 2023 (view filing)Mar 12 daysCrowley John FExecutive ChairmanSSale−6.04K$13.42−$81.1K−0.6%992.6K after2 lots
Mar 3, 2023 (view filing)Mar 12 daysCampbell Bradley LPresident & CEOSSale−20.0K$13.25−$264.9K−2.3%836.8K after2 lots
Feb 16, 2023 (view filing)Feb 151 dayCrowley John FExecutive ChairmanSSale−6.04K$12.94−$78.2K−0.6%998.6K after
Feb 3, 2023 (view filing)Feb 12 daysCrowley John FExecutive ChairmanSSale−147.3K$13.11−$1.93M−12.8%1.00M after
Feb 3, 2023 (view filing)Feb 12 daysCampbell Bradley LPresident & CEOSSale−20.0K$12.98−$259.6K−2.3%845.1K after
Jan 25, 2023 (view filing)Jan 241 dayRosenberg EllenChief Legal OfficerSSale−31.8K$13.32−$424.1K−8.7%332.3K after
Jan 19, 2023 (view filing)Jan 181 dayClark David MichaelChief People OfficerSSale−7.38K$13.50−$99.7K−3.0%241.1K after
Jan 19, 2023 (view filing)Jan 17-182 daysQuimi DaphneChief Financial OfficerSSale−11.9K$12.79−$152.4K−2.9%398.5K after2 lots
Jan 17, 2023 (view filing)Jan 134 daysMcGlynn Margaret GDirectorSSale−15.0K$13.03−$195.4K−22.8%50.7K after
Jan 11, 2023 (view filing)Jan 92 daysCrowley John FExecutive ChairmanSSale−85.1K$11.43−$972.7K−8.8%885.2K after
Jan 11, 2023 (view filing)Jan 92 daysCampbell Bradley LPresident & CEOSSale−11.7K$11.43−$133.7K−1.4%805.5K after
Jan 6, 2023 (view filing)Jan 6Same dayClark David MichaelChief People OfficerSSale−21.5K$11.87−$255.3K−8.9%219.6K after
Jan 4, 2023 (view filing)Jan 31 dayClark David MichaelChief People OfficerSSale−8.49K$12.03−$102.2K−4.3%190.2K after
Dec 19, 2022 (view filing)Dec 154 daysCrowley John FExecutive ChairmanSSale−10.5K$12.15−$127.2K−1.3%791.5K after
Dec 5, 2022 (view filing)Dec 14 daysCrowley John FExecutive ChairmanSSale−11.3K$12.20−$138.4K−1.4%801.9K after
Dec 5, 2022 (view filing)Dec 14 daysCampbell Bradley LPresident & CEOSSale−5.49K$12.20−$66.9K−0.8%689.6K after
Nov 17, 2022 (view filing)Nov 152 daysCrowley John FExecutive ChairmanSSale−10.5K$11.64−$121.8K−1.3%813.3K after
Nov 3, 2022 (view filing)Nov 12 daysCrowley John FExecutive ChairmanSSale−11.3K$10.32−$117.1K−1.4%823.7K after
Nov 3, 2022 (view filing)Nov 12 daysCampbell Bradley LPresident & CEOSSale−5.47K$10.01−$54.8K−0.8%689.6K after
Oct 19, 2022 (view filing)Oct 172 daysCrowley John FExecutive ChairmanSSale−10.5K$10.90−$114.1K−1.2%835.1K after
Oct 5, 2022 (view filing)Oct 32 daysCrowley John FExecutive ChairmanSSale−11.3K$10.75−$122.0K−1.3%845.6K after
Oct 5, 2022 (view filing)Oct 32 daysCampbell Bradley LPresident & CEOSSale−5.47K$10.53−$57.6K−0.8%689.6K after
Sep 19, 2022 (view filing)Sep 154 daysCrowley John FExecutive ChairmanSSale−10.5K$10.66−$111.6K−1.2%856.9K after
Sep 6, 2022 (view filing)Sep 15 daysQuimi DaphneChief Financial OfficerSSale−4.40K$11.29−$49.6K−1.3%335.3K after
Sep 6, 2022 (view filing)Sep 15 daysCrowley John FExecutive ChairmanSSale−11.3K$11.30−$128.2K−1.3%867.4K after